Gene Symbol | Gene ID | Gene Info |
---|---|---|
Esr1
|
ENSMUSG00000019768.10 | estrogen receptor 1 (alpha) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_4710044_4710195 | Esr1 | 36 | 0.986786 | -0.58 | 3.2e-06 | Click! |
chr10_4885605_4885756 | Esr1 | 37290 | 0.206826 | -0.58 | 3.4e-06 | Click! |
chr10_4599076_4599227 | Esr1 | 12442 | 0.204039 | -0.50 | 1.1e-04 | Click! |
chr10_4675102_4675253 | Esr1 | 34978 | 0.200435 | -0.49 | 1.6e-04 | Click! |
chr10_4885297_4885448 | Esr1 | 37598 | 0.205900 | -0.46 | 3.9e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr18_36274707_36275097 | 10.77 |
Pura |
purine rich element binding protein A |
6195 |
0.2 |
chr18_82162363_82162777 | 4.64 |
Gm50294 |
predicted gene, 50294 |
95940 |
0.06 |
chr3_104762286_104762711 | 4.57 |
Gm6485 |
predicted gene 6485 |
9333 |
0.09 |
chr2_165884402_165885933 | 4.34 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr14_14351950_14353283 | 4.30 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr5_145464693_145465010 | 3.89 |
Cyp3a16 |
cytochrome P450, family 3, subfamily a, polypeptide 16 |
4872 |
0.19 |
chr6_127321540_127321865 | 3.88 |
Gm43636 |
predicted gene 43636 |
3361 |
0.16 |
chr11_78074361_78074827 | 3.85 |
Mir451b |
microRNA 451b |
1353 |
0.16 |
chr5_135108172_135108560 | 3.85 |
Mlxipl |
MLX interacting protein-like |
1448 |
0.24 |
chr14_69540059_69540582 | 3.44 |
Gm27174 |
predicted gene 27174 |
15012 |
0.09 |
chr14_69321815_69322332 | 3.44 |
Gm16677 |
predicted gene, 16677 |
15009 |
0.09 |
chr8_123181510_123181661 | 3.37 |
Dpep1 |
dipeptidase 1 |
4657 |
0.08 |
chr3_65658208_65659857 | 3.34 |
Mir8120 |
microRNA 8120 |
256 |
0.89 |
chr7_135593820_135594195 | 3.31 |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
619 |
0.73 |
chr8_70698268_70700333 | 3.23 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr11_87763473_87764852 | 3.20 |
Tspoap1 |
TSPO associated protein 1 |
569 |
0.56 |
chr2_167343431_167343599 | 3.17 |
B4galt5 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 |
5668 |
0.21 |
chr16_18428816_18428997 | 3.17 |
Txnrd2 |
thioredoxin reductase 2 |
19 |
0.95 |
chr1_168287679_168288893 | 3.14 |
Gm37524 |
predicted gene, 37524 |
49385 |
0.16 |
chr17_45747884_45748074 | 3.10 |
F630040K05Rik |
RIKEN cDNA F630040K05 gene |
8731 |
0.14 |
chr6_30146983_30147411 | 3.08 |
Mir182 |
microRNA 182 |
18795 |
0.12 |
chr11_30648868_30649937 | 3.07 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr17_79350758_79351146 | 3.02 |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
2055 |
0.34 |
chr18_64325939_64326090 | 3.00 |
St8sia3os |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3, opposite strand |
7692 |
0.17 |
chr10_41262026_41262186 | 2.92 |
Fig4 |
FIG4 phosphoinositide 5-phosphatase |
41154 |
0.11 |
chr11_75443495_75443793 | 2.90 |
Serpinf2 |
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
4053 |
0.09 |
chr4_46041817_46041999 | 2.87 |
Tmod1 |
tropomodulin 1 |
2699 |
0.27 |
chr13_24977580_24978022 | 2.85 |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
15174 |
0.13 |
chr13_11836757_11837070 | 2.85 |
Ryr2 |
ryanodine receptor 2, cardiac |
7259 |
0.24 |
chr1_136929822_136930079 | 2.83 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
10633 |
0.23 |
chr8_123051729_123051936 | 2.80 |
2810013P06Rik |
RIKEN cDNA 2810013P06 gene |
9366 |
0.1 |
chr7_80451646_80451837 | 2.79 |
Blm |
Bloom syndrome, RecQ like helicase |
5631 |
0.14 |
chr17_34210626_34210847 | 2.76 |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
3030 |
0.09 |
chr9_74930005_74930274 | 2.74 |
Fam214a |
family with sequence similarity 214, member A |
22745 |
0.17 |
chr11_105152665_105152916 | 2.73 |
Gm11620 |
predicted gene 11620 |
13830 |
0.13 |
chr11_44509325_44509652 | 2.72 |
Rnf145 |
ring finger protein 145 |
9476 |
0.16 |
chr8_126720623_126720806 | 2.71 |
Gm45805 |
predicted gene 45805 |
37620 |
0.18 |
chr19_17323963_17324132 | 2.71 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
11389 |
0.21 |
chr16_90449803_90450060 | 2.70 |
Hunk |
hormonally upregulated Neu-associated kinase |
11966 |
0.2 |
chr2_129227429_129227604 | 2.70 |
A730036I17Rik |
RIKEN cDNA A730036I17 gene |
506 |
0.56 |
chr2_32083621_32084073 | 2.69 |
Fam78a |
family with sequence similarity 78, member A |
64 |
0.95 |
chr5_145800955_145801237 | 2.66 |
Cyp3a44 |
cytochrome P450, family 3, subfamily a, polypeptide 44 |
4778 |
0.18 |
chr14_70336335_70336839 | 2.66 |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
2389 |
0.19 |
chr12_55820249_55821283 | 2.66 |
Ralgapa1 |
Ral GTPase activating protein, alpha subunit 1 |
1 |
0.61 |
chr1_80030774_80030937 | 2.65 |
Gm28058 |
predicted gene 28058 |
67767 |
0.09 |
chr12_32142869_32143111 | 2.63 |
5430401H09Rik |
RIKEN cDNA 5430401H09 gene |
19288 |
0.17 |
chr6_7844118_7845326 | 2.62 |
C1galt1 |
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
120 |
0.95 |
chr17_83684505_83684810 | 2.61 |
Mta3 |
metastasis associated 3 |
21506 |
0.21 |
chr9_66769338_66769700 | 2.58 |
Car12 |
carbonic anhydrase 12 |
21809 |
0.12 |
chr10_81095272_81095757 | 2.56 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
2939 |
0.1 |
chr12_84962360_84962600 | 2.54 |
Arel1 |
apoptosis resistant E3 ubiquitin protein ligase 1 |
3550 |
0.16 |
chr8_122329580_122330425 | 2.51 |
Zfpm1 |
zinc finger protein, multitype 1 |
3696 |
0.15 |
chr17_87276537_87277114 | 2.51 |
4833418N02Rik |
RIKEN cDNA 4833418N02 gene |
4868 |
0.16 |
chr8_122546140_122546405 | 2.50 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
5057 |
0.1 |
chr15_38543923_38544446 | 2.50 |
Azin1 |
antizyme inhibitor 1 |
24918 |
0.1 |
chr6_87740576_87740855 | 2.48 |
Efcc1 |
EF hand and coiled-coil domain containing 1 |
7906 |
0.09 |
chr2_23562943_23563247 | 2.47 |
Spopl |
speckle-type BTB/POZ protein-like |
8883 |
0.24 |
chr10_89670377_89670727 | 2.47 |
Scyl2 |
SCY1-like 2 (S. cerevisiae) |
10391 |
0.18 |
chr1_86525613_86527056 | 2.45 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr19_40769316_40769607 | 2.45 |
Cc2d2b |
coiled-coil and C2 domain containing 2B |
4909 |
0.21 |
chr4_45483923_45484361 | 2.43 |
Shb |
src homology 2 domain-containing transforming protein B |
1340 |
0.39 |
chr1_87961921_87962076 | 2.43 |
Usp40 |
ubiquitin specific peptidase 40 |
5197 |
0.13 |
chrX_142359130_142359442 | 2.42 |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
31058 |
0.12 |
chr5_145715169_145715451 | 2.42 |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
4826 |
0.2 |
chr10_89422792_89422943 | 2.41 |
Gas2l3 |
growth arrest-specific 2 like 3 |
10975 |
0.25 |
chr8_122341257_122341572 | 2.39 |
Gm45353 |
predicted gene 45353 |
2243 |
0.19 |
chr1_166002288_166003185 | 2.38 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr9_72409226_72409810 | 2.38 |
Gm27255 |
predicted gene 27255 |
250 |
0.55 |
chr5_105565602_105565788 | 2.38 |
Lrrc8c |
leucine rich repeat containing 8 family, member C |
6837 |
0.21 |
chr17_83651316_83651614 | 2.38 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
19570 |
0.22 |
chr10_79897376_79897662 | 2.37 |
Med16 |
mediator complex subunit 16 |
2166 |
0.09 |
chr9_96266895_96267069 | 2.36 |
Gm28924 |
predicted gene 28924 |
3119 |
0.23 |
chr18_32543067_32543441 | 2.36 |
Gypc |
glycophorin C |
7836 |
0.2 |
chr15_83377234_83377427 | 2.35 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
7761 |
0.15 |
chr6_90320619_90320802 | 2.35 |
Chst13 |
carbohydrate sulfotransferase 13 |
4475 |
0.12 |
chr12_24890162_24890450 | 2.35 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
58675 |
0.09 |
chr7_132772857_132773208 | 2.34 |
Fam53b |
family with sequence similarity 53, member B |
3884 |
0.24 |
chr6_86598895_86599245 | 2.33 |
Gm44369 |
predicted gene, 44369 |
7640 |
0.11 |
chr8_80683770_80684060 | 2.32 |
Smarca5 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
26946 |
0.18 |
chr3_100488535_100489982 | 2.30 |
Tent5c |
terminal nucleotidyltransferase 5C |
60 |
0.85 |
chr2_153492229_153493481 | 2.30 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr1_172202190_172203478 | 2.29 |
Pea15a |
phosphoprotein enriched in astrocytes 15A |
3019 |
0.13 |
chr8_94178954_94179363 | 2.29 |
Mt1 |
metallothionein 1 |
53 |
0.95 |
chr3_104599330_104600023 | 2.29 |
Gm26091 |
predicted gene, 26091 |
1563 |
0.27 |
chr11_117790740_117791162 | 2.28 |
Tmc8 |
transmembrane channel-like gene family 8 |
237 |
0.58 |
chr6_120174417_120174862 | 2.26 |
Ninj2 |
ninjurin 2 |
19184 |
0.18 |
chr4_132075006_132075723 | 2.26 |
Epb41 |
erythrocyte membrane protein band 4.1 |
43 |
0.91 |
chr9_120114727_120115009 | 2.26 |
Slc25a38 |
solute carrier family 25, member 38 |
18 |
0.94 |
chr11_4223413_4223698 | 2.25 |
Castor1 |
cytosolic arginine sensor for mTORC1 subunit 1 |
5330 |
0.1 |
chr1_185469823_185470016 | 2.25 |
Gm2061 |
predicted gene 2061 |
14351 |
0.12 |
chr8_84197696_84198961 | 2.25 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr12_24686000_24686681 | 2.21 |
Cys1 |
cystin 1 |
4527 |
0.16 |
chr2_155989607_155989792 | 2.21 |
Cep250 |
centrosomal protein 250 |
3784 |
0.13 |
chr15_36640888_36641046 | 2.21 |
Gm6704 |
predicted gene 6704 |
11098 |
0.13 |
chr14_70468127_70468616 | 2.19 |
Phyhip |
phytanoyl-CoA hydroxylase interacting protein |
9848 |
0.1 |
chr11_65650060_65650234 | 2.19 |
Gm26128 |
predicted gene, 26128 |
23753 |
0.21 |
chr10_128036790_128037106 | 2.18 |
Naca |
nascent polypeptide-associated complex alpha polypeptide |
1313 |
0.23 |
chr19_55284094_55284395 | 2.18 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
90 |
0.97 |
chr15_76545778_76546051 | 2.17 |
Slc52a2 |
solute carrier protein 52, member 2 |
6950 |
0.07 |
chr10_75078495_75078712 | 2.17 |
Bcr |
BCR activator of RhoGEF and GTPase |
18011 |
0.16 |
chr11_115449732_115450144 | 2.17 |
Mir3968 |
microRNA 3968 |
1878 |
0.15 |
chr5_145643078_145643229 | 2.16 |
Cyp3a63-ps |
cytochrome P450, family 3, subfamily a, member 63, pseudogene |
9160 |
0.16 |
chr7_45708987_45709454 | 2.15 |
Dbp |
D site albumin promoter binding protein |
1331 |
0.17 |
chr1_23998505_23998704 | 2.15 |
Gm26524 |
predicted gene, 26524 |
6901 |
0.18 |
chr5_8894851_8895125 | 2.14 |
Abcb4 |
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
1039 |
0.47 |
chr3_28775529_28775686 | 2.13 |
1700112D23Rik |
RIKEN cDNA 1700112D23 gene |
5501 |
0.13 |
chr5_145579733_145580022 | 2.12 |
Cyp3a41b |
cytochrome P450, family 3, subfamily a, polypeptide 41B |
4853 |
0.18 |
chr9_63757305_63758776 | 2.11 |
Smad3 |
SMAD family member 3 |
46 |
0.98 |
chr11_78982143_78982376 | 2.10 |
Lgals9 |
lectin, galactose binding, soluble 9 |
2572 |
0.27 |
chr14_70466265_70466449 | 2.10 |
Phyhip |
phytanoyl-CoA hydroxylase interacting protein |
7834 |
0.1 |
chr1_191856101_191856285 | 2.10 |
Nek2 |
NIMA (never in mitosis gene a)-related expressed kinase 2 |
29045 |
0.11 |
chr8_124948019_124949972 | 2.10 |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
329 |
0.85 |
chr10_80604137_80604304 | 2.09 |
Adat3 |
adenosine deaminase, tRNA-specific 3 |
968 |
0.24 |
chr11_31843587_31843752 | 2.09 |
Gm12107 |
predicted gene 12107 |
11009 |
0.19 |
chr7_66187835_66188252 | 2.08 |
Gm45080 |
predicted gene 45080 |
2512 |
0.23 |
chr11_58353112_58353501 | 2.08 |
Sh3bp5l |
SH3 binding domain protein 5 like |
7994 |
0.1 |
chr11_95808504_95808830 | 2.08 |
Phospho1 |
phosphatase, orphan 1 |
15832 |
0.1 |
chr6_32534186_32534346 | 2.08 |
Plxna4os1 |
plexin A4, opposite strand 1 |
23193 |
0.2 |
chr12_83302133_83303175 | 2.07 |
Dpf3 |
D4, zinc and double PHD fingers, family 3 |
8226 |
0.28 |
chr7_127768560_127769629 | 2.06 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr1_36920168_36920628 | 2.06 |
Gm38115 |
predicted gene, 38115 |
3859 |
0.16 |
chr8_105966447_105966892 | 2.06 |
Slc12a4 |
solute carrier family 12, member 4 |
572 |
0.48 |
chr12_111516879_111517219 | 2.06 |
Gm40578 |
predicted gene, 40578 |
16209 |
0.1 |
chr7_79269506_79269840 | 2.06 |
Gm31510 |
predicted gene, 31510 |
3138 |
0.18 |
chr6_38342333_38342771 | 2.05 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
11721 |
0.13 |
chr1_93432204_93432382 | 2.04 |
Hdlbp |
high density lipoprotein (HDL) binding protein |
8499 |
0.12 |
chr11_70092126_70092295 | 2.04 |
Asgr2 |
asialoglycoprotein receptor 2 |
434 |
0.69 |
chr2_146099017_146099372 | 2.04 |
Cfap61 |
cilia and flagella associated protein 61 |
51943 |
0.15 |
chr1_87712037_87712211 | 2.03 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
2783 |
0.24 |
chr1_73036588_73036920 | 2.03 |
1700027A15Rik |
RIKEN cDNA 1700027A15 gene |
12185 |
0.22 |
chr19_4059281_4059805 | 2.02 |
Gstp3 |
glutathione S-transferase pi 3 |
26 |
0.92 |
chr6_124471862_124472027 | 2.02 |
Gm50463 |
predicted gene, 50463 |
5179 |
0.11 |
chr5_67815801_67816118 | 2.02 |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
106 |
0.95 |
chr17_71268606_71269006 | 2.02 |
Emilin2 |
elastin microfibril interfacer 2 |
209 |
0.92 |
chr1_193001497_193001909 | 2.02 |
Syt14 |
synaptotagmin XIV |
33941 |
0.13 |
chr13_100864073_100864234 | 2.01 |
Gm37830 |
predicted gene, 37830 |
8627 |
0.14 |
chr2_142399542_142399832 | 2.01 |
Rpl26-ps5 |
ribosomal protein L26, pseudogene 5 |
170821 |
0.03 |
chr4_147897388_147897711 | 2.01 |
Gm13156 |
predicted gene 13156 |
3876 |
0.12 |
chr5_134913846_134914156 | 2.01 |
Cldn13 |
claudin 13 |
1525 |
0.2 |
chr6_140768890_140769790 | 1.99 |
Gm43925 |
predicted gene, 43925 |
15364 |
0.19 |
chr2_91636780_91637296 | 1.99 |
F2 |
coagulation factor II |
624 |
0.58 |
chr14_30875458_30875850 | 1.99 |
Stimate |
STIM activating enhancer |
3299 |
0.15 |
chr19_32180169_32180459 | 1.99 |
Sgms1 |
sphingomyelin synthase 1 |
16114 |
0.21 |
chr17_84934381_84934779 | 1.99 |
Ppm1b |
protein phosphatase 1B, magnesium dependent, beta isoform |
22161 |
0.14 |
chr5_29925630_29925782 | 1.99 |
Gm43386 |
predicted gene 43386 |
25012 |
0.14 |
chr6_113690907_113691133 | 1.99 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
275 |
0.73 |
chr15_79044857_79045121 | 1.98 |
Galr3 |
galanin receptor 3 |
3104 |
0.09 |
chr11_29815794_29815966 | 1.98 |
Eml6 |
echinoderm microtubule associated protein like 6 |
5782 |
0.17 |
chr3_89147017_89147649 | 1.98 |
Hcn3 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 3 |
3881 |
0.08 |
chr2_23026514_23026711 | 1.98 |
Gm13357 |
predicted gene 13357 |
6945 |
0.18 |
chr11_79071029_79071376 | 1.98 |
Ksr1 |
kinase suppressor of ras 1 |
3284 |
0.27 |
chr10_121429894_121430401 | 1.98 |
Gm18730 |
predicted gene, 18730 |
29434 |
0.1 |
chr6_21789559_21789710 | 1.98 |
Tspan12 |
tetraspanin 12 |
62194 |
0.11 |
chr4_152013511_152013898 | 1.97 |
Gm9768 |
predicted gene 9768 |
4085 |
0.11 |
chr7_63999241_63999848 | 1.97 |
Gm32633 |
predicted gene, 32633 |
2341 |
0.24 |
chr11_95823907_95824556 | 1.97 |
Phospho1 |
phosphatase, orphan 1 |
268 |
0.85 |
chr19_32227307_32227475 | 1.97 |
Sgms1 |
sphingomyelin synthase 1 |
11421 |
0.22 |
chr11_95800592_95800866 | 1.97 |
Phospho1 |
phosphatase, orphan 1 |
23770 |
0.1 |
chr4_133557474_133557769 | 1.96 |
Gm23158 |
predicted gene, 23158 |
1328 |
0.26 |
chr1_181335118_181335287 | 1.96 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
17426 |
0.15 |
chr19_34074266_34074421 | 1.96 |
Gm23334 |
predicted gene, 23334 |
5412 |
0.15 |
chr7_101324201_101324364 | 1.96 |
Gm20476 |
predicted gene 20476 |
1949 |
0.18 |
chr17_5112509_5112660 | 1.95 |
Gm15599 |
predicted gene 15599 |
474 |
0.87 |
chr3_116562756_116563068 | 1.95 |
Lrrc39 |
leucine rich repeat containing 39 |
61 |
0.93 |
chr18_82167769_82168053 | 1.94 |
Gm50294 |
predicted gene, 50294 |
90599 |
0.07 |
chr6_67013674_67013895 | 1.94 |
Gm15644 |
predicted gene 15644 |
1299 |
0.3 |
chr2_167344198_167344362 | 1.94 |
B4galt5 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 |
4903 |
0.22 |
chr18_32542832_32543024 | 1.93 |
Gypc |
glycophorin C |
7510 |
0.2 |
chr5_74064910_74065186 | 1.93 |
Usp46 |
ubiquitin specific peptidase 46 |
700 |
0.53 |
chr14_47241050_47241230 | 1.92 |
Wdhd1 |
WD repeat and HMG-box DNA binding protein 1 |
4130 |
0.11 |
chr7_110156726_110157216 | 1.92 |
1600010M07Rik |
RIKEN cDNA 1600010M07 gene |
5769 |
0.16 |
chr18_3005171_3005609 | 1.92 |
Gm50072 |
predicted gene, 50072 |
10518 |
0.21 |
chr4_142053332_142053558 | 1.92 |
Gm13053 |
predicted gene 13053 |
4867 |
0.15 |
chr11_31830043_31830943 | 1.92 |
Gm12107 |
predicted gene 12107 |
2167 |
0.31 |
chr1_136007953_136008157 | 1.92 |
Tmem9 |
transmembrane protein 9 |
95 |
0.95 |
chr5_122136615_122137053 | 1.91 |
Ccdc63 |
coiled-coil domain containing 63 |
1228 |
0.37 |
chr5_139383216_139383491 | 1.91 |
Gpr146 |
G protein-coupled receptor 146 |
2772 |
0.16 |
chr11_7153175_7153391 | 1.91 |
Adcy1 |
adenylate cyclase 1 |
6599 |
0.21 |
chr13_52831701_52831898 | 1.91 |
BB123696 |
expressed sequence BB123696 |
74594 |
0.1 |
chr17_23546226_23547548 | 1.90 |
6330415G19Rik |
RIKEN cDNA 6330415G19 gene |
3912 |
0.1 |
chr13_111744433_111744584 | 1.90 |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
6865 |
0.15 |
chr11_78069689_78070032 | 1.90 |
Mir144 |
microRNA 144 |
3145 |
0.1 |
chr4_46040327_46040637 | 1.90 |
Tmod1 |
tropomodulin 1 |
1273 |
0.46 |
chr9_112996220_112996412 | 1.89 |
Gm36251 |
predicted gene, 36251 |
126713 |
0.06 |
chr19_6291067_6291820 | 1.89 |
Ehd1 |
EH-domain containing 1 |
2738 |
0.11 |
chr5_122501856_122502977 | 1.89 |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
191 |
0.88 |
chr19_31868623_31868825 | 1.89 |
A1cf |
APOBEC1 complementation factor |
40 |
0.98 |
chr2_121289033_121290183 | 1.89 |
Map1a |
microtubule-associated protein 1 A |
8 |
0.96 |
chr12_118186213_118186414 | 1.89 |
Dnah11 |
dynein, axonemal, heavy chain 11 |
12730 |
0.25 |
chr8_123813265_123813430 | 1.89 |
Rab4a |
RAB4A, member RAS oncogene family |
7279 |
0.1 |
chr6_34157215_34157595 | 1.88 |
Gm13856 |
predicted gene 13856 |
5476 |
0.19 |
chr2_28602260_28602441 | 1.88 |
Gm22824 |
predicted gene, 22824 |
5845 |
0.11 |
chr2_31462664_31462815 | 1.88 |
Ass1 |
argininosuccinate synthetase 1 |
7468 |
0.19 |
chr8_70843407_70843727 | 1.88 |
Arrdc2 |
arrestin domain containing 2 |
3847 |
0.09 |
chr5_123223029_123223358 | 1.87 |
Psmd9 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 |
4997 |
0.12 |
chr2_4573003_4573185 | 1.87 |
Frmd4a |
FERM domain containing 4A |
6918 |
0.21 |
chr6_91146547_91147358 | 1.87 |
Hdac11 |
histone deacetylase 11 |
9713 |
0.13 |
chr10_75697073_75697253 | 1.87 |
Cabin1 |
calcineurin binding protein 1 |
3212 |
0.18 |
chr10_53335552_53335703 | 1.87 |
Pln |
phospholamban |
2040 |
0.22 |
chr8_94186149_94186588 | 1.86 |
Gm39228 |
predicted gene, 39228 |
3079 |
0.13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.5 | 4.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.3 | 5.4 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.1 | 3.3 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.1 | 1.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.0 | 1.0 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.0 | 1.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
1.0 | 3.0 | GO:0008050 | female courtship behavior(GO:0008050) |
1.0 | 2.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.9 | 2.7 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.9 | 2.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.8 | 0.8 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.8 | 0.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.8 | 2.4 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.8 | 1.6 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.8 | 3.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.8 | 3.8 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.7 | 2.2 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.7 | 2.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.7 | 2.9 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.7 | 2.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.7 | 0.7 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.7 | 6.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.7 | 2.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.7 | 3.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.7 | 2.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.7 | 2.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.6 | 2.6 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.6 | 1.9 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 2.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.6 | 1.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.6 | 1.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.6 | 0.6 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.6 | 1.8 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.6 | 2.4 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.6 | 3.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 3.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 1.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.6 | 2.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.6 | 1.7 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.6 | 1.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.6 | 3.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.6 | 1.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 4.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.5 | 2.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.5 | 2.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 2.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.5 | 2.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 1.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 3.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.5 | 3.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 2.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.5 | 1.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.5 | 1.5 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.5 | 0.5 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.5 | 1.5 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.5 | 0.5 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.5 | 2.0 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.5 | 11.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 1.5 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.5 | 1.4 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.5 | 1.9 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.5 | 0.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.5 | 1.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.5 | 1.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 3.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.4 | 2.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.4 | 1.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.4 | 2.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 0.4 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.4 | 1.8 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 2.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.4 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.4 | 3.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.4 | 0.9 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.4 | 1.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 1.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 1.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.4 | 1.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 0.9 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.4 | 1.7 | GO:0070627 | ferrous iron import(GO:0070627) |
0.4 | 1.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 1.7 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.4 | 1.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.4 | 2.5 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.4 | 7.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 1.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.4 | 1.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 0.8 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.4 | 2.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.4 | 2.8 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.4 | 2.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.4 | 0.8 | GO:1901563 | response to camptothecin(GO:1901563) |
0.4 | 1.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 1.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.4 | 1.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.4 | 1.2 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.4 | 0.8 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.4 | 0.8 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 2.7 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.4 | 1.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.4 | 0.8 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 0.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 0.8 | GO:0032782 | bile acid secretion(GO:0032782) |
0.4 | 1.2 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.4 | 1.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 0.8 | GO:0061511 | centriole elongation(GO:0061511) |
0.4 | 1.5 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.4 | 1.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 0.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.4 | 0.8 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.4 | 1.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 1.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 0.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.4 | 1.1 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 1.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.4 | 1.9 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 0.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.4 | 1.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 2.6 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.4 | 1.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 1.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 1.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.4 | 2.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.4 | 1.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.4 | 0.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.4 | 1.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 1.8 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.4 | 1.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.4 | 1.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.4 | 2.8 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.4 | 1.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 1.1 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.4 | 0.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 1.4 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.3 | 1.0 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 1.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 4.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 1.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 1.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.3 | 1.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.3 | 1.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 1.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 0.7 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.3 | 1.7 | GO:1904970 | brush border assembly(GO:1904970) |
0.3 | 1.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 0.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 3.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 0.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 0.7 | GO:0019627 | urea metabolic process(GO:0019627) |
0.3 | 1.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 0.7 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.3 | 1.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 1.0 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.3 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 0.7 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.3 | 2.0 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 0.7 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.3 | 2.6 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 1.3 | GO:2001184 | regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 1.0 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 0.3 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.3 | 0.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.3 | 0.6 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.3 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 6.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.3 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 0.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.3 | 1.6 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 1.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 0.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 3.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 0.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 1.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 0.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.3 | 2.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 1.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 0.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.3 | 1.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.3 | 3.7 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.3 | 0.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 1.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 2.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 1.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 2.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.3 | 1.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.3 | 0.3 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.3 | 0.6 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.3 | 1.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 0.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 0.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.3 | 0.9 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.3 | 1.2 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 1.8 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 1.5 | GO:0042168 | heme metabolic process(GO:0042168) |
0.3 | 1.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 1.5 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 1.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 1.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 1.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 2.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.3 | 0.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 0.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.3 | 2.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 0.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 1.7 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 1.2 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 0.9 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.3 | 6.0 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.3 | 1.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.9 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.3 | 5.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.3 | 2.0 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 0.8 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 1.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 0.6 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.3 | 0.8 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 1.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 1.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.3 | 0.3 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.3 | 5.8 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 0.3 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.3 | 0.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 0.8 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 1.4 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 0.3 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.3 | 0.8 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 0.8 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 0.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 1.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 1.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 0.8 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.3 | 1.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.3 | 1.8 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 1.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.3 | 1.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 1.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 1.3 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 0.5 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.3 | 0.3 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.3 | 0.3 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.3 | 0.5 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.3 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.3 | 1.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 3.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 1.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 0.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 | 1.8 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 3.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 0.8 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 0.8 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.3 | 0.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.5 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.3 | 1.8 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.3 | 2.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.3 | 1.0 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.3 | 1.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 0.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.3 | 0.5 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.3 | 0.5 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.3 | 2.3 | GO:0043486 | histone exchange(GO:0043486) |
0.3 | 1.0 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.3 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 1.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 0.5 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 2.2 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 1.2 | GO:0015669 | gas transport(GO:0015669) carbon dioxide transport(GO:0015670) |
0.2 | 1.0 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.2 | 2.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 1.0 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.2 | 1.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.2 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 1.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.2 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.2 | 1.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.2 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 1.2 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 0.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 1.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.7 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 0.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.7 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) sinoatrial node cell development(GO:0060931) |
0.2 | 5.0 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.2 | 0.7 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 1.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.7 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.2 | 1.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.2 | 1.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 1.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 2.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 5.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 2.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 2.3 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 2.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 1.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.7 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 1.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 1.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.2 | 0.7 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.9 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 1.6 | GO:0070254 | mucus secretion(GO:0070254) |
0.2 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.9 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 0.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 3.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 2.2 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 0.7 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.2 | 1.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.2 | 0.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.9 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.9 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 2.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 2.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 2.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 2.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.4 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.9 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.2 | 0.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.9 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 0.4 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 1.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.4 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.9 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 0.6 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.2 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.2 | 0.9 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.2 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 3.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.2 | 0.6 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.2 | 2.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 1.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.6 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 0.6 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.2 | 1.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.2 | 0.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 1.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 0.6 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.2 | 1.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 0.4 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.2 | 1.4 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.2 | 0.4 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 1.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 1.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 2.0 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 2.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 2.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.6 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 1.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 0.6 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.2 | 2.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.2 | 1.6 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.6 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.2 | 1.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.8 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.2 | 0.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 1.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.8 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 1.8 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 1.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 1.4 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 0.4 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.2 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 0.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 1.0 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.2 | 1.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.6 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 0.2 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.2 | 0.4 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 1.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.2 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.2 | 0.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.8 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.2 | 0.4 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.2 | 2.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 1.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.8 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.2 | 0.2 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.2 | 1.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 2.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.9 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.4 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.4 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.2 | 0.2 | GO:1902302 | potassium ion export across plasma membrane(GO:0097623) regulation of potassium ion export(GO:1902302) |
0.2 | 0.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.9 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.2 | 0.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 3.7 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 0.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 0.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 1.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.2 | 0.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.2 | 0.2 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 0.2 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.2 | 0.7 | GO:0007343 | egg activation(GO:0007343) |
0.2 | 0.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.4 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.4 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.2 | 0.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.4 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 2.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 1.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 1.6 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 0.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 1.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 0.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 0.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 1.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 1.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.5 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 0.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 0.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 0.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.2 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 1.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.3 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 0.5 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.2 | 1.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 1.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.2 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.2 | 0.7 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.2 | 0.3 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.2 | 0.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 1.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 1.5 | GO:0071548 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.2 | 0.2 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.2 | 2.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.3 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.2 | 0.7 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 2.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.7 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 0.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 0.3 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 1.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.2 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.2 | 1.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.2 | 0.8 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.2 | 1.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 1.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 1.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 0.8 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 1.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 0.6 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.2 | 2.2 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.2 | 2.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 1.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 0.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 0.2 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.2 | 0.9 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.5 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 1.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 0.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.8 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.3 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 0.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 2.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 0.6 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.2 | 3.4 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.2 | 0.5 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.2 | 1.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.5 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.2 | 0.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 2.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 0.2 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.2 | 1.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 0.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.2 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.5 | GO:0000393 | generation of catalytic spliceosome for second transesterification step(GO:0000350) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 0.5 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.2 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 1.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.6 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) pharyngeal arch artery morphogenesis(GO:0061626) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 0.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 1.9 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 4.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.4 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 1.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 1.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 1.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.3 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 1.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 1.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 2.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.4 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 1.1 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.1 | 2.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.7 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.3 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.1 | 0.4 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 1.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 1.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.6 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.1 | 1.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 1.4 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.0 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.1 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) deoxyribose phosphate catabolic process(GO:0046386) |
0.1 | 0.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.1 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 0.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 1.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.5 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.1 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.3 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.1 | 4.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 2.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 2.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.9 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.1 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.1 | 2.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.1 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 1.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 1.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.8 | GO:0035510 | DNA dealkylation(GO:0035510) DNA demethylation(GO:0080111) |
0.1 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.5 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 1.5 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.1 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.3 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.3 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 2.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.9 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.5 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 2.9 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.4 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.1 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 1.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.1 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 2.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 1.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 1.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.1 | 0.8 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.4 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.2 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.2 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.9 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.1 | 0.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.3 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.1 | 0.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.8 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.6 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.2 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.1 | 0.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.1 | 0.6 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.6 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 1.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 3.0 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.6 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.1 | 1.8 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.3 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.2 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 1.0 | GO:0009220 | pyrimidine ribonucleotide biosynthetic process(GO:0009220) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.3 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 4.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.3 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:1903596 | regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
0.1 | 0.4 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 1.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.1 | GO:0033206 | meiotic cytokinesis(GO:0033206) polar body extrusion after meiotic divisions(GO:0040038) |
0.1 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.4 | GO:0051196 | regulation of coenzyme metabolic process(GO:0051196) |
0.1 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 1.8 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 2.4 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.5 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.8 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 1.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.3 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.1 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.5 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.3 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.3 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.1 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.2 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.4 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 1.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 1.5 | GO:0048821 | erythrocyte development(GO:0048821) |
0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 2.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.9 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.5 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 2.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.3 | GO:2000303 | regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.4 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.1 | GO:0033034 | positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.1 | 0.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.7 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.1 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 1.1 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 1.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 2.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.2 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.5 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.5 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.2 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 1.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.1 | 0.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.3 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 0.3 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.3 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.3 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 1.6 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.2 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.1 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.3 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.1 | 3.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.6 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 1.3 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.1 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.3 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 1.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 1.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.2 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.7 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.3 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.2 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.2 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.2 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.4 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 2.4 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.3 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.1 | 0.7 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.2 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.1 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 2.8 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.3 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.5 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.1 | 1.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.2 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.2 | GO:0071435 | potassium ion export(GO:0071435) |
0.1 | 0.2 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.1 | 0.9 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
0.1 | 0.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.1 | GO:0052205 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.1 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.4 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 2.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.6 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 1.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.2 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 2.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.3 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.1 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.1 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.1 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.4 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 1.9 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.2 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 3.8 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.7 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.1 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.1 | 0.7 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.3 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 1.2 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.1 | 0.5 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.1 | 0.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.3 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.1 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.1 | 0.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.3 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 2.3 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.1 | 0.9 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.1 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 0.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.1 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) |
0.1 | 0.1 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.1 | 0.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.4 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.1 | GO:0001774 | microglial cell activation(GO:0001774) |
0.1 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.7 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 1.1 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.1 | 1.2 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 0.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.6 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 1.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.2 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.2 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.1 | 0.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.1 | GO:0060789 | negative regulation of hair follicle development(GO:0051799) hair follicle placode formation(GO:0060789) |
0.1 | 0.2 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.1 | GO:0034369 | macromolecular complex remodeling(GO:0034367) protein-lipid complex remodeling(GO:0034368) plasma lipoprotein particle remodeling(GO:0034369) |
0.1 | 0.1 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.1 | 2.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.1 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 0.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.1 | GO:1904714 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.3 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.5 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.1 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.2 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.1 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.4 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 1.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:1902884 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) |
0.1 | 0.1 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.4 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.2 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 2.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.0 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 1.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 1.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.3 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.0 | 0.0 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) follicle-stimulating hormone secretion(GO:0046884) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.5 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 1.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.0 | 0.2 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.0 | 0.0 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.0 | 0.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.0 | 0.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.4 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.2 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.5 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 2.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.0 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.0 | 0.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 1.2 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.0 | 0.0 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.0 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.0 | 0.0 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.0 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.0 | 0.6 | GO:0007127 | meiosis I(GO:0007127) |
0.0 | 0.5 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.2 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.2 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.0 | 0.1 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.0 | 1.3 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.0 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.4 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 0.0 | GO:0039528 | cytoplasmic pattern recognition receptor signaling pathway in response to virus(GO:0039528) |
0.0 | 0.6 | GO:0016101 | retinoid metabolic process(GO:0001523) diterpenoid metabolic process(GO:0016101) |
0.0 | 0.3 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.0 | 0.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.2 | GO:0046218 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.4 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.3 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.0 | 0.3 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.0 | 0.2 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 1.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.0 | 0.4 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.0 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.0 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.1 | GO:0044144 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.1 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.1 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.0 | 0.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.0 | 0.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.0 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.0 | 0.0 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) |
0.0 | 0.0 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.0 | 0.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.0 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.0 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) negative regulation of cytolysis(GO:0045918) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 1.2 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.1 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.8 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.5 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.3 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.0 | 0.2 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.1 | GO:0019068 | virion assembly(GO:0019068) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.7 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.1 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.0 | 0.0 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 1.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.1 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.0 | 0.0 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.0 | 0.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.0 | 0.1 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.1 | GO:0031343 | positive regulation of cell killing(GO:0031343) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.0 | 0.1 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.0 | 0.0 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.1 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.0 | 0.0 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.4 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.6 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.0 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.0 | 0.0 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.0 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.0 | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) |
0.0 | 0.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 1.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.4 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.5 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.5 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.0 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.3 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.0 | 0.0 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.0 | 0.1 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.0 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.2 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.0 | 0.0 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 1.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.0 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.7 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.0 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.0 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.0 | 0.0 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.0 | 0.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 1.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.0 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.8 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 1.0 | GO:0048193 | Golgi vesicle transport(GO:0048193) |
0.0 | 0.0 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.0 | 0.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.0 | 2.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.0 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.0 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.0 | 0.0 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.0 | 0.0 | GO:0002891 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.0 | 0.0 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.0 | 0.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.9 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.5 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.8 | 4.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.8 | 2.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.7 | 2.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 0.7 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.6 | 3.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 6.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.6 | 2.3 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 1.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 1.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 3.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.5 | 2.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 1.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 1.9 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.5 | 1.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 4.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 2.2 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 2.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 3.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 1.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 1.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 0.4 | GO:0042827 | platelet dense granule(GO:0042827) |
0.4 | 1.2 | GO:1990462 | omegasome(GO:1990462) |
0.4 | 4.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 1.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 1.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 1.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 2.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 3.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 1.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 2.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 1.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 2.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 1.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 1.3 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 0.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.3 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 0.9 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 0.9 | GO:0035061 | interchromatin granule(GO:0035061) |
0.3 | 1.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 0.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 1.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 0.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 0.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 1.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 1.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 1.1 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 0.8 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.3 | 1.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 0.8 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 0.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 2.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 0.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 1.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 1.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 2.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 11.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 2.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 1.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 7.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.7 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 1.9 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 16.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.5 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 3.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 1.4 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 3.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 3.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 2.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 1.1 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 1.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.2 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.2 | 1.4 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 0.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 1.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.6 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 1.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 6.7 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 2.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 2.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 1.7 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 1.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.9 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 3.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 1.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.4 | GO:0045240 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.2 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 2.4 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 3.1 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 6.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 1.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 0.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 2.0 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 3.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 2.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 0.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 2.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 13.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 1.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 3.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 4.0 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.2 | 1.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 2.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 3.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 11.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 1.3 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 1.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.5 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 0.3 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.2 | 0.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 1.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 2.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 3.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 6.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 3.0 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 0.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.6 | GO:0036452 | ESCRT I complex(GO:0000813) ESCRT complex(GO:0036452) |
0.1 | 1.1 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 2.3 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.5 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.7 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.1 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 5.3 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 1.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 4.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.3 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 2.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 1.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.4 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 1.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.8 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.1 | 4.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.8 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.7 | GO:0030894 | replisome(GO:0030894) |
0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.9 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 5.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.4 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.6 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 6.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 1.0 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 3.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 3.0 | GO:0031672 | A band(GO:0031672) |
0.1 | 1.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 1.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 1.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 2.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 2.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 1.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 5.3 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 1.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 3.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 2.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 4.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.3 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 3.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 2.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 4.7 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.9 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 1.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 3.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.0 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 1.0 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 2.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 2.1 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.4 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.1 | 0.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.4 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 1.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 2.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 6.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 0.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.5 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 8.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 4.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 5.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 6.1 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 2.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 3.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 2.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.4 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 3.0 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 7.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 3.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 22.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 1.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 1.4 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.6 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 1.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.8 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.7 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.8 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.1 | 2.6 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 50.6 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 5.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.4 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.0 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 14.6 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 31.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.1 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 3.5 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.0 | 2.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 7.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 3.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.6 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 16.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 4.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.4 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.3 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.0 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 8.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 1.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.1 | 4.3 | GO:0009374 | biotin binding(GO:0009374) |
1.0 | 6.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.9 | 6.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.8 | 2.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 2.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 2.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.7 | 3.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.7 | 3.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.7 | 5.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.7 | 2.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.7 | 2.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.7 | 1.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.6 | 1.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.6 | 1.8 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.6 | 1.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 3.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.6 | 2.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.6 | 1.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.5 | 2.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 1.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.5 | 1.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 1.0 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 2.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 1.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 3.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 1.5 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.5 | 1.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.5 | 1.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 3.8 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 1.9 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.5 | 1.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.5 | 1.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.5 | 1.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 3.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.4 | 1.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.4 | 4.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 2.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.4 | 2.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 1.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 0.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.4 | 1.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 0.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.4 | 1.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 3.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 1.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 0.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 1.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.4 | 1.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 2.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 0.8 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.4 | 1.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 2.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 1.6 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.4 | 0.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.4 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.2 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 1.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 3.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.4 | 1.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 0.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 2.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 1.1 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 1.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 1.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 0.7 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.4 | 1.5 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 0.4 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.4 | 0.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.4 | 2.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 2.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 1.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.4 | 1.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.4 | 1.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 1.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 2.4 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 2.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 1.0 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 2.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.3 | GO:0032564 | dATP binding(GO:0032564) |
0.3 | 0.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 6.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 0.6 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 1.0 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.3 | 1.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.3 | 1.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 3.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.6 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 2.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 1.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 1.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 1.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.3 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.3 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 0.9 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 1.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 1.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 1.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.3 | 2.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.3 | 2.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 3.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 1.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 1.2 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 2.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 1.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 0.9 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 0.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 0.9 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.3 | 0.8 | GO:0035877 | death effector domain binding(GO:0035877) |
0.3 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 3.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 1.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 0.8 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.3 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 1.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 6.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 0.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 3.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 2.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 1.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 1.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 1.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 1.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 1.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 1.1 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 2.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 0.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 0.8 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 0.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 1.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 0.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 2.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 1.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 1.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 1.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 1.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 1.8 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 1.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 7.2 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 1.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 0.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 2.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 3.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 2.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 2.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 2.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 5.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 4.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 3.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 3.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.5 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 0.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.5 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 3.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 0.2 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.2 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 1.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 4.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 3.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 4.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 1.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.8 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 1.5 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.2 | GO:0035276 | ethanol binding(GO:0035276) |
0.2 | 0.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 1.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 2.6 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 0.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 4.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 2.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 0.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 1.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.2 | GO:0015927 | trehalase activity(GO:0015927) |
0.2 | 1.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 1.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 1.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 2.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 1.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 0.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 2.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 1.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 1.0 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 2.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 2.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 0.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 1.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 1.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 0.8 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 3.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.6 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 2.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.2 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.2 | 0.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 3.0 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 1.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 0.6 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 4.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 5.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.2 | 1.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 0.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 0.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.2 | 1.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.7 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.2 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.2 | 1.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.5 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
0.2 | 2.2 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 2.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 1.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 1.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 1.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 2.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.8 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 0.5 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 2.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 1.7 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.2 | 2.8 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 6.1 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 0.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 0.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.6 | GO:0035173 | histone kinase activity(GO:0035173) histone serine kinase activity(GO:0035174) |
0.2 | 0.9 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 2.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 1.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 3.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.9 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 1.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.1 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 1.3 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 1.3 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.1 | 0.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.1 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.1 | 1.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 1.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.1 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.1 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 0.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.9 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 1.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 2.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 1.0 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 1.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 3.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 1.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 3.4 | GO:0043905 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.1 | 1.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 3.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 1.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 1.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 2.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 2.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 2.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.1 | 0.8 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.1 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 4.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 1.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.2 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 7.5 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 1.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 10.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 5.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 2.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.1 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 5.0 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 1.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 3.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.8 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.6 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.2 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 1.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 3.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 1.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 2.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.4 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 6.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 5.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 1.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 1.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 2.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 1.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.3 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 1.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 2.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.4 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 1.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 4.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 2.9 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 2.0 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 8.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.7 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.1 | 7.5 | GO:0070735 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 1.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.2 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 1.7 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 1.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 2.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 1.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 1.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 2.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.8 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.7 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 1.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 3.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 8.9 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.7 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 3.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 5.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.5 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 2.7 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.1 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.1 | 3.5 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 2.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 1.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.0 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 1.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 2.6 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.0 | 8.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.3 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 1.1 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.0 | 0.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.4 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.2 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.0 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 1.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.0 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 2.4 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 0.5 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.6 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 1.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.7 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 3.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.0 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.0 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.0 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 1.3 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 2.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.3 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.0 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.5 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 1.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 6.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.0 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.0 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.0 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.0 | GO:0005119 | smoothened binding(GO:0005119) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 6.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 18.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 5.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 5.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 5.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 5.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 9.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 0.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 2.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 2.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 4.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 4.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 4.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 3.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 1.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 4.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 6.9 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 7.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 3.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 1.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 3.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 1.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 7.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 6.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 2.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 5.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.2 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 2.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.0 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 2.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 4.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 2.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 6.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.8 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 2.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 6.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 3.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 2.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 3.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 3.1 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 2.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 2.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 3.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 1.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 4.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 0.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 5.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 10.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 7.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 9.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 2.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 4.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.4 | 3.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 2.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 5.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 4.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 0.8 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.4 | 4.8 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.4 | 1.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 4.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.3 | 5.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 3.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 0.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 4.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 1.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 4.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 1.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 3.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 4.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 3.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 2.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 2.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 3.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 3.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 2.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 4.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 2.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 2.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 0.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 3.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 2.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.2 | 3.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 0.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 10.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 3.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 5.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 4.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 0.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.2 | 4.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 1.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 2.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 1.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 1.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 1.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 1.0 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.2 | 17.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 1.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 1.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 4.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 5.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 8.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 5.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 4.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 2.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 5.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 1.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 0.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 2.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 1.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 2.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 1.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 2.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 1.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.2 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.2 | 1.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 2.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 0.6 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.2 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 0.8 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.2 | 8.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 1.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 1.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 3.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 5.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 3.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 2.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 3.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 1.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.9 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.8 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 0.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 3.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 1.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 9.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 2.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 2.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 2.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.8 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 1.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 4.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 3.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.5 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.1 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.2 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 1.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 6.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 3.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 5.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 1.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 7.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.1 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.1 | 0.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 7.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 1.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.8 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.0 | 0.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 1.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.1 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.0 | 0.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |